Company profile for BostonGene

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Immuno- and targeted therapies are the most promising and rapidly developing treatments for many types of cancer. BostonGene guides you through all the innovative and classical treatments, helping cancer patients worldwide. BostonGene is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. Our unique solution continuously aggregates ...
Immuno- and targeted therapies are the most promising and rapidly developing treatments for many types of cancer. BostonGene guides you through all the innovative and classical treatments, helping cancer patients worldwide. BostonGene is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. Our unique solution continuously aggregates the latest cancer research and clinical information from around the world creating an interactive knowledgebase. BostonGene integrates the analysis of individual tumor genetics, molecular composition, etc

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
University Office Park III, 95 Sawyer Road, Waltham, MA 02453
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

PBP World Meeting

Not Confirmed

envelop Contact Supplier

PBP World Meeting

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-03-17/bostongene-named-innovator-of-the-year-at-boston-life-sciences-times-vanguard-awards

PHARMIWEB
17 Mar 2026

https://www.businesswire.com/news/home/20260303897260/en/BostonGene-and-Unilever-Partner-to-Apply-AI-and-Multiomics-Research-to-Support-Consumer-Innovation

BUSINESSWIRE
03 Mar 2026

https://www.businesswire.com/news/home/20260302161064/en/BostonGene-to-Highlight-the-Role-of-AI-Foundation-Models-in-Optimizing-Cancer-Immunotherapy-at-Precision-Medicine-World-Conference-2026

BUSINESSWIRE
02 Mar 2026

https://www.pharmiweb.com/press-release/2026-02-24/bostongene-ceo-andrew-feinberg-to-deliver-keynote-at-mobile-world-congress-barcelona-2026

PHARMIWEB
24 Feb 2026

https://www.businesswire.com/news/home/20260203533686/en/Independent-Multi-Vendor-Study-Validates-BostonGenes-AI-for-Precision-HER2-Scoring

BUSINESSWIRE
03 Feb 2026

https://www.businesswire.com/news/home/20260108720749/en/BostonGene-Announces-Collaboration-with-Ottimo-Pharma-to-Optimize-and-Accelerate-Development-of-First-in-Class-PD-1VEGFR2-Immuno-Oncology-Therapy-Using-AI

BUSINESSWIRE
08 Jan 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty